 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/12/2024 |
$11.88 |
$12.05 |
$11.70 |
$11.89 |
237.90K | | 04/15/2024 |
$11.82 |
$12.01 |
$11.50 |
$11.74 |
313.50K | | 04/16/2024 |
$11.53 |
$12.17 |
$11.47 |
$11.88 |
489.70K | | 04/17/2024 |
$11.80 |
$11.94 |
$11.65 |
$11.65 |
298.70K | | 04/18/2024 |
$11.53 |
$11.75 |
$11.28 |
$11.50 |
408.70K |
|
|
| KalVista Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors for diseases with unmet need. Co. has develop small molecule plasma kallikrein inhibitors targeting the disease hereditary angioedema (HAE). Co. also is conducting preclinical development on an oral Factor XIIa inhibitor program, which Co. is initially improving to provide HAE therapeutics. Co. has developed its candidate sebetralstat into clinical development as a potential oral, on-demand therapy for HAE attacks. Co. also is developing an oral disintegrating tablet formulation of sebetralstat. | |
|
KalVista Pharmaceuticals (KALV) has the following price history information. Looking back at KALV historical stock prices for the last five trading days, on April 12, 2024, KALV opened at $11.88, traded as high as $12.05 and as low as $11.70, and closed at $11.89. Trading volume was a total of 237.90K shares. On April 15, 2024, KALV opened at $11.82, traded as high as $12.01 and as low as $11.50, and closed at $11.74. Trading volume was a total of 313.50K shares. On April 16, 2024, KALV opened at $11.53, traded as high as $12.17 and as low as $11.47, and closed at $11.88. Trading volume was a total of 489.70K shares. On April 17, 2024, KALV opened at $11.80, traded as high as $11.94 and as low as $11.65, and closed at $11.65. Trading volume was a total of 298.70K shares. On April 18, 2024, KALV opened at $11.53, traded as high as $11.75 and as low as $11.28, and closed at $11.50. Trading volume was a total of 408.70K shares.
KALV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into KalVista Pharmaceuticals shares, starting with a $10,000 purchase of KALV, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/10/2015 |
|
| End date: |
04/18/2024 |
|
| Start price/share: |
$74.06 |
|
| End price/share: |
$11.50 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-84.47% |
|
| Average Annual Total Return: |
-18.64% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,552.38 |
|
| Years: |
9.03 |
|
|
|
| Date |
Close |
| 04/12/2024 | $11.89 | | 04/15/2024 | $11.74 | | 04/16/2024 | $11.88 | | 04/17/2024 | $11.65 | | 04/18/2024 | $11.50 |
|
|
Free KALV Email Alerts:
